Related Experiment Video
Updated: Jun 8, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis
Roberta Magliozzi1,2, Owain W Howell3,4, Massimiliano Calabrese3
1Neurology Section of Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy. roberta.magliozzi@univr.it.
Abstract:
Growing evidence from cerebrospinal fluid samples and post-mortem brain tissue from individuals with multiple sclerosis (MS) and rodent models indicates that the meninges have a key role in the inflammatory and neurodegenerative mechanisms underlying progressive MS pathology. The subarachnoid space and associated perivascular spaces between the membranes of the meninges are the access points for entry of lymphocytes, monocytes and macrophages into the brain parenchyma, and the main route for diffusion of inflammatory and cytotoxic molecules from the cerebrospinal fluid into the brain tissue. In addition, the meningeal spaces act as an exit route for CNS-derived antigens, immune cells and metabolites. A number of studies have demonstrated an association between chronic meningeal inflammation and a more severe clinical course of MS, suggesting that the build-up of immune cell aggregates in the meninges represents a rational target for therapeutic intervention. Therefore, understanding the precise cell and molecular mechanisms, timing and anatomical features involved in the compartmentalization of inflammation within the meningeal spaces in MS is vital. Here, we present a detailed review and discussion of the cellular, molecular and radiological evidence for a role of meningeal inflammation in MS, alongside the clinical and therapeutic implications.
Insights
The meninges, or brain membranes, play a crucial role in multiple sclerosis (MS) inflammation and neurodegeneration. Targeting meningeal inflammation offers a promising therapeutic strategy for progressive MS.
Area of Science:
- Neuroimmunology
- Neuropathology
Background:
- The meninges are increasingly recognized for their role in the inflammatory and neurodegenerative processes of progressive multiple sclerosis (MS).
- The subarachnoid and perivascular spaces within the meninges facilitate immune cell entry and inflammatory molecule diffusion into the brain parenchyma.
- Meningeal spaces also serve as a route for the egress of central nervous system (CNS)-derived components.
Purpose of the Study:
- To review and discuss the cellular, molecular, and radiological evidence implicating meningeal inflammation in MS pathogenesis.
- To explore the clinical and therapeutic implications of meningeal inflammation in MS.
Main Methods:
- Review of existing literature on cellular, molecular, and radiological findings related to meningeal inflammation in MS.
- Analysis of cerebrospinal fluid and post-mortem brain tissue studies in MS patients and animal models.
Main Results:
- Chronic meningeal inflammation is associated with a more severe clinical course in MS.
- Immune cell aggregates in the meninges are implicated in MS pathology.
- Understanding meningeal compartmentalization of inflammation is vital for therapeutic development.
Conclusions:
- The meninges are a critical site for immune activity in MS.
- Targeting meningeal inflammation represents a potential therapeutic avenue for progressive MS.
- Further research into the precise mechanisms of meningeal involvement in MS is warranted.
Related Concept Videos
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Cerebral Edema ll: Pathophysiology

